Confirming the efficacy and safety of CDK4/6 inhibitors in the first-line treatment of HR+ advanced breast cancer: a systematic review and meta-analysis

Overview of attention for article published in Frontiers in Pharmacology, August 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,872 followers.

New Research: Confirming the efficacy and safety of CDK4/6 inhibitors in the first-line treatment of HR+ advanced breast cancer: a systematic review and meta-analysis https://t.co/wTJTJrPkZA #FrontiersIn #Pharmacology

05 Aug 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.